Archive for March 2nd, 2010

• Apples HTC patent suit: Can it derail Googles Android devices?

  March 2, 2010

  [Story ID: 660] Apple said Tuesday that it is suing HTC for infringing on 20 patents related to the iPhone and pursuing a permanent cease and desist order that could derail a wide range of Android devices. by Larry Dignan

  posted in Uncategorized by admin

• HappyWakeUp 1.4 (Mobile)

  March 2, 2010

  [Story ID: 922] No more groggy mornings, thanks to HappyWakeUp. Using smart phone technology and medical research findings, this application knows the optimal time to arouse you from sleep. Youll feel refreshed each and every morning with this award winning program. Click ‘More’ to learn why you should download this App.HappyWakeUp won second…

  posted in Uncategorized by admin

• BioSante Pharmaceuticals announces receipt of two US patents directed to 2A/Furin technology (News-Medical-Net)

  March 2, 2010

  [Story ID: 686] BioSante Pharmaceuticals, Inc. today announced the receipt of two US patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,632,059, covers methods for manufacturing recombinant antibodies.

  posted in Uncategorized by admin

• Gene research offers new hope for targeted breast cancer treatment

  March 2, 2010

  [Story ID: 650] CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

  posted in Uncategorized by admin

• Catholic directive may thwart end-of-life wishes

  March 2, 2010

  [Story ID: 651] Kaiser Health News reports on questions resulting from a directive passed last November in Tulsa, Okla. “An elderly woman taken last year to St. John Medical Center in Tulsa, Okla., had suffered a massive stroke and could no longer speak, eat or drink.

  posted in Uncategorized by admin

• NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD

  March 2, 2010

  [Story ID: 652] NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries [...]

  posted in Uncategorized by admin

• Belatacept Biologics License Application: FDA drug advisory committee recommends approval

  March 2, 2010

  [Story ID: 653] Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration’

  posted in Uncategorized by admin

• Pelosi confident on health overhaul vote through reconciliation process

  March 2, 2010

  [Story ID: 654] House Speaker Nancy Pelosi is “confident” she will be able to get the votes needed to pass health care reform, “even if it threatens the political careers of some members of her party,” The New York Times reports.

  posted in Uncategorized by admin

• Study indicates GABA neurotransmitters could play a key role in major depressive disorder

  March 2, 2010

  [Story ID: 655] The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.

  posted in Uncategorized by admin

• Nuclear Regulatory Commission licenses Positron facility in Fishers to handle radioactive material

  March 2, 2010

  [Story ID: 656] Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the Nuclear Regulatory Commission has licensed the Positron facility in Fishers, Indiana to handle radioactive material.

  posted in Uncategorized by admin